SP7 Mouse mAb Protocol: IHC, WB & IF Applications

SP7 Mouse mAb is a monoclonal antibody targeting the SP7 (Osterix) transcription factor, supplied in PBS and optimized for use in immunohistochemistry, western blotting, and immunofluorescence applications to detect osteoblast lineage cells.

Product SKU

Ab351396

Antibody Type

Mouse Monoclonal Antibody (mAb)

Target Protein

SP7 (Osterix), a zinc-finger transcription factor essential for osteoblast differentiation

Formulation

PBS (phosphate-buffered saline) only; no carrier proteins or preservatives indicated

Recommended Applications

IHC, Western Blot (WB), Immunofluorescence (IF)

Storage Recommendation

Store at -20°C; avoid repeated freeze-thaw cycles (standard practice for PBS-formulated mAbs)

Materials Required

Before beginning, ensure the following reagents and equipment are available:

• Primary antibody: SP7 Mouse mAb (Ab351396), stored at -20°C
• Tissue/cell samples: formalin-fixed paraffin-embedded (FFPE) sections or frozen sections for IHC; cultured cells on coverslips for IF; lysates for WB
• Blocking buffer: 5% normal serum (species matched to secondary antibody host) or 3–5% BSA in TBST
• Secondary antibody: Anti-mouse IgG conjugated to HRP (for IHC/WB) or fluorophore (for IF)
• Antigen retrieval buffer: Citrate buffer pH 6.0 or EDTA buffer pH 9.0 (for FFPE IHC)
• Wash buffer: TBST (TBS + 0.1% Tween-20) or PBST
• Detection reagents: DAB substrate kit (IHC), ECL reagent (WB), or mounting medium with DAPI (IF)
• Equipment: Pressure cooker or microwave (antigen retrieval), rocking platform, gel electrophoresis apparatus (WB), fluorescence microscope (IF)

Sample Preparation

For IHC (FFPE sections):

1. Deparaffinize sections in xylene (2 × 5 min) and rehydrate through a graded ethanol series (100%, 95%, 70%) to distilled water.
2. Perform heat-induced epitope retrieval (HIER): immerse slides in citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) and heat for 10–20 min using a pressure cooker or microwave. Allow slides to cool for 20–30 min at room temperature.
3. Rinse sections three times with TBST (5 min each).
4. Quench endogenous peroxidase activity by incubating in 3% H₂O₂ in methanol for 10 min (for HRP-based detection).
5. Rinse three times with TBST.

For Western Blot:

1. Lyse cells or homogenize tissue in RIPA buffer supplemented with protease inhibitor cocktail on ice.
2. Centrifuge at 12,000 × g for 15 min at 4°C; collect supernatant.
3. Determine protein concentration by BCA or Bradford assay.
4. Denature samples in SDS loading buffer at 95°C for 5 min before loading.

For Immunofluorescence:

1. Fix cells in 4% paraformaldehyde in PBS for 15 min at room temperature.
2. Wash three times with PBS.
3. Permeabilize with 0.1–0.2% Triton X-100 in PBS for 10 min (SP7 is a nuclear transcription factor; permeabilization is essential).
4. Wash three times with PBS.

Antibody Incubation and Detection

Blocking: Incubate samples in blocking buffer (5% normal serum or 3% BSA in TBST/PBST) for 60 min at room temperature in a humidified chamber (IHC/IF) or with gentle agitation (WB membrane).

Primary Antibody Incubation (SP7 Mouse mAb, Ab351396):

• Dilute the antibody in blocking buffer to the manufacturer-recommended working concentration. Optimal dilution should be determined empirically for each application and sample type.
• Incubate overnight at 4°C with gentle rocking (recommended for all three applications) or for 1–2 hours at room temperature.

Washing: After primary antibody incubation, wash samples three to five times with TBST (5 min per wash) to remove unbound antibody.

Secondary Antibody Incubation:

• Apply appropriate anti-mouse IgG secondary antibody at recommended dilution in blocking buffer.
• Incubate for 60 min at room temperature, protected from light if using a fluorescent secondary.

Detection:

• IHC: Apply DAB substrate solution; monitor color development under microscope; stop reaction with water. Counterstain with hematoxylin if desired. Dehydrate, clear, and mount sections.
• WB: Apply ECL substrate and expose to film or imaging system. SP7/Osterix is expected to migrate at approximately 45–60 kDa on SDS-PAGE.
• IF: Mount coverslips with DAPI-containing mounting medium. Image using appropriate excitation/emission filters.

Troubleshooting

Problem	Possible Cause	Suggested Solution
No signal detected	Insufficient antigen retrieval; antibody too dilute; target not expressed in sample	Optimize retrieval buffer and time; titrate antibody concentration; use a positive control tissue (e.g., bone or osteosarcoma)
High background	Insufficient blocking; primary antibody concentration too high; inadequate washing	Extend blocking time to 2 hours; reduce primary antibody concentration; increase number or duration of washes
Non-specific bands on WB	Excess antibody; cross-reactivity; incomplete transfer	Increase wash stringency; optimize antibody dilution; verify transfer efficiency with Ponceau S staining
Nuclear signal absent (IF)	Insufficient permeabilization	Increase Triton X-100 concentration (up to 0.5%) or extend permeabilization time; SP7 is nuclear, so cytoplasmic signal alone indicates permeabilization failure
Weak or inconsistent signal	Antibody degraded; excessive freeze-thaw cycles	Prepare single-use aliquots upon first use; store at -20°C and avoid freeze-thaw cycling

Expected Results and Controls

Expected Staining Pattern: SP7 (Osterix) is a nuclear transcription factor expressed specifically in osteoblasts and odontoblasts. Positive signal should therefore be localized to the nucleus. In bone tissue sections, signal is expected in osteoblasts lining bone surfaces and in osteocytes embedded within the bone matrix.

Positive Controls: Use sections or lysates derived from bone tissue, osteosarcoma cell lines, or any cell line known to differentiate along the osteoblast lineage. These tissue types are expected to show robust SP7 expression.

Negative Controls:

• Isotype control: Replace primary antibody with a matched mouse IgG isotype control at the same concentration to assess non-specific binding.
• Primary antibody omission control: Omit primary antibody but proceed with all subsequent steps to confirm that secondary antibody alone does not produce signal.

Molecular Weight (WB): The SP7/Osterix protein is expected to appear as a band in the approximately 45–60 kDa range on reducing SDS-PAGE. Confirm band identity using positive control lysate.

Note: All expected results and molecular weight ranges are based on general knowledge of SP7 biology. Verify against datasheet specifications upon receipt of product.

Frequently asked questions

What buffer is SP7 Mouse mAb (Ab351396) supplied in, and how should it be stored?

SP7 Mouse mAb (Ab351396) is supplied in PBS (phosphate-buffered saline) without carrier proteins or preservatives as indicated. It should be stored at -20°C for long-term storage. To preserve activity, prepare single-use aliquots upon first thaw and avoid repeated freeze-thaw cycles.

Which applications is SP7 Mouse mAb recommended for?

SP7 Mouse mAb (Ab351396) is recommended for immunohistochemistry (IHC), western blotting (WB), and immunofluorescence (IF). Optimal working dilutions should be determined empirically for each application, sample type, and detection system used.

Why is antigen retrieval necessary for SP7 IHC on FFPE sections, and which buffer is recommended?

Formalin fixation creates cross-links between proteins that can mask epitopes and prevent antibody binding. Heat-induced epitope retrieval (HIER) reverses these cross-links and restores antigenicity. Both citrate buffer (pH 6.0) and EDTA buffer (pH 9.0) are commonly used for nuclear transcription factors such as SP7; the optimal buffer should be determined empirically for this antibody-tissue combination.

Why must cells be permeabilized before using SP7 Mouse mAb in immunofluorescence?

SP7 (Osterix) is a nuclear transcription factor. The cell membrane is impermeable to antibodies under standard fixation conditions. Permeabilization with a mild detergent such as Triton X-100 (0.1–0.2%) creates pores in the plasma and nuclear membranes, allowing the antibody to access and bind the nuclear SP7 protein. Omitting this step will result in absent or very weak nuclear signal.

What positive control tissue or cell line should be used when validating SP7 Mouse mAb?

Bone tissue sections, osteosarcoma-derived cell lines, or osteoblast-differentiating cell cultures are suitable positive controls for SP7 antibody validation, as SP7/Osterix is a master regulator specifically expressed in osteoblast lineage cells. Tissues with no expected SP7 expression should be used as negative controls.

References

1. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108(1):17-29. doi:10.1016/S0092-8674(01)00622-5
2. Aladdin Scientific. SP7 Mouse mAb, Product Ab351396. Product datasheet. [Manufacturer's documentation; consult current datasheet for validated dilutions and lot-specific data.]

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.